11/06/2024
3:27 PM | NovoCure (Issuer)
Paravasthu Mukund (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
6:02 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
6:00 AM | NovoCure (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/15/2024
3:05 PM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
5:21 PM | NovoCure (Issuer)
Paravasthu Mukund (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/03/2024
6:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
3:16 PM | NovoCure (Issuer)
Puri Michal Nath (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/06/2024
3:17 PM | Leonard Frank X (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:19 PM | Cordova Ashley (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:19 PM | Danziger Asaf (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
7:19 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:20 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:21 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:22 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:24 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:25 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:16 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:17 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:18 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
6:01 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2024
6:05 AM | NovoCure (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/10/2024
12:14 PM | NovoCure (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
NovoCure (Subject)
| Form SC 13G/A | |
06/06/2024
5:37 PM | NovoCure (Issuer)
Ocean Allyson J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:13 PM | Madden Martin J. (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:55 PM | Hung David (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:42 PM | LEUNG GABRIEL (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:42 PM | NovoCure (Issuer)
Scannell Timothy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:43 PM | NovoCure (Issuer)
VERNON W ANTHONY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:43 PM | NovoCure (Issuer)
Stafford Kristin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:09 PM | HILLEMAN JERYL L (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
7:01 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
6:01 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
6:01 AM | NovoCure (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/27/2024
6:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
5:39 PM | NovoCure (Subject)
Shah Pritesh (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
5:17 PM | GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
3:43 PM | Cordova Ashley (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:33 PM | Giladi Moshe (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:33 PM | Leupin Nicolas (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:35 PM | NovoCure (Issuer)
Weinberg Uri (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad) Trump's back in the White House, but Wall Street is pissed.
Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. |
02/22/2024
6:11 AM | NovoCure (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/22/2024
6:05 AM | NovoCure (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2024
6:06 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
8:28 AM | FMR LLC (Filed by)
NovoCure (Subject)
| Form SC 13G/A | |
01/18/2024
6:01 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/12/2024
3:57 PM | Leonard Frank X (Reporting)
NovoCure (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/11/2024
4:15 PM | Leupin Nicolas (Reporting)
NovoCure (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/09/2024
6:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:10 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:10 PM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
3:23 PM | Giladi Moshe (Reporting)
NovoCure (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/11/2023
5:19 AM | Capital World Investors (Filed by)
NovoCure (Subject)
| Form SC 13G/A | |
11/28/2023
6:30 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
